Page 132 - 《中国药房》2022年2期

[38] BENJAMIN E J，BLAHA M J，CHIUVE S E，et al. Heart genation-induced cardiac myocyte apoptosis via Akt/
disease and stroke statistics-2017 update：a report from FoxO1 pathway[J]. Med Sci Monit，2020，26：e923195.
the American Heart Association[J]. Circulation，2017，135 DOI：10.12659/MSM.923195.
（10）：e146-e603. [52] LOMONOSOVAY N，SHENKMAN B S，NEMIROVSKAYA
[39] LA COUR J L，CHRISTENSEN H M，KÖHRLE J，et al. T L. Attenuation of unloading-induced rat soleus atrophy
Association between 3-iodothyronamine（T1AM）concen- with the heat-shock protein inducer 17-（allylamino）-17-
trations and left ventricular function in chronic heart fai- demethoxygeldanamycin[J]. FASEB J，2012，26（10）：
lure[J]. J Clin Endocrinol Metab，2019，104（4）：1232- 4295-4301.
1238. [53] JU H，KIM T，CHUNG C M，et al. Metabolic suppression
[40] LV J N，LIAO J，TAN W，et al. 3-iodothyronamine acting by 3-iodothyronamine induced muscle cell atrophy via ac-
through an anti-apoptotic mechanism is neuroprotective tivation of FoxO-proteasome signaling and downregula-
against spinal cord injury in rats[J]. Ann Clin Lab Sci， tion of Akt1-S6K signaling[J]. Biol Pharm Bull，2017，40
2018，48（6）：736-742. （5）：576-582.
[41] BANGERT C，RINDLER K，KRAUSGRUBER T，et al. [54] ROGOWSKI M，BELLUSCI L，SABATINI M，et al. Lipo-
Persistence of mature dendritic cells，TH2A，and Tc2 cells lytic effects of 3-iodothyronamine（T1AM）and a novel
characterize clinically resolved atopic dermatitis under thyronamine-like analog SG-2 through the AMPK path-
IL-4Rα blockade[J]. Sci Immunol，2021，6（55）：eabe2749. way[J]. Int J Mol Sci，2019，20（16）：E4054.
[42] DINTER J，KHAJAVI N，MÜHLHAUS J，et al. The multi- [55] JU H，SHIN H，SON C，et al. 3-Iodothyronamine-media-
target ligand 3-iodothyronamine modulates β-adrenergic ted metabolic suppression increases the phosphorylation
receptor 2 signaling[J]. Eur Thyroid J，2015，4（Suppl 1）： of AMPK and induces fuel choice toward lipid mobiliza-
21-29. tion[J]. Horm Metab Res，2014，47（8）：605-610.
[43] TOMINAGA M，CATERINA M J. Thermosensation and [56] KIM M，PARK K，CHOI I. The metabolic suppressor 3-io-
pain[J]. J Neurobiol，2004，61（1）：3-12. dothyronamine enhances lipolysis in 3T3-L1 adipocytes
[44] TOMINAGA M，TOMINAGA T. Structure and function via activation of the adenosine monophosphate-activated
of TRPV1[J]. Pflügers Arch，2005，451（1）：143-150. protein kinase/forkhead box O1 signaling pathway[J]. J
[45] NILIUS B，OWSIANIK G，VOETS T，et al. Transient re- Physiol pharmacol，2020，71（3）：409-416.
ceptor potential cation channels in disease[J]. Physiol [57] RINE J，STRATHERN J N，HICKS J B，et al. A suppres-
Rev，2007，87（1）：165-217. sor of mating-type locus mutations in Saccharomyces cere-
[46] KHAJAVI N，REINACH P S，SLAVI N，et al. Thyro- visiae：evidence for and identification of cryptic ma-
namine induces TRPM8 channel activation in human con- ting-type loci[J]. Genetics，1979，93（4）：877-901.
junctival epithelial cells[J]. Cell Signal，2015，27（2）：315- [58] HSU Y C，WU Y T，TSAI C L，et al. Current understan-
325. ding and future perspectives of the roles of sirtuins in the
[47] KENNETT G A，DOURISH C T，CURZON G. 5-HT1B reprogramming and differentiation of pluripotent stem
agonists induce anorexia at a postsynaptic site[J]. Eur J cells[J]. Exp Biol Med（Maywood），2018，243（6）：563-
Pharmacol，1987，141（3）：429-435. 575.
[48] BRÄUNIG J，DINTER J，HÖFIG C S，et al. The trace [59] ASSADI-PORTER F M，REILAND H，SABATINI M，et
amine-associated receptor 1 agonist 3-iodothyronamine in- al. Metabolic reprogramming by 3-iodothyronamine
duces biased signaling at the serotonin 1b receptor[J]. （T1AM）：a new perspective to reverse obesity through
Front Pharmacol，2018，9：222. co-regulation of sirtuin 4 and 6 expression[J]. Int J Mol
[49] LAURINO A，MATUCCI R，VISTOLI G，et al. 3-iodothy- Sci，2018，19（5）：E1535.
ronamine（T1AM），a novel antagonist of muscarinic re- [60] BELLUSCI L，LAURINO A，SABATINI M，et al. New in-
ceptors[J]. Eur J Pharmacol，2016，793：35-42. sights into the potential roles of 3-iodothyronamine
[50] Correction to：heart disease and stroke statistics-2017 up- （T1AM）and newly developed thyronamine-like TAAR1
date：a report from the American Heart Association[J]. Cir- agonists in neuroprotection[J]. Front Pharmacol，2017，8：
culation，2017，135（10）：e646 905.
[51] ZHOU H Y，HU B L，LIU X D. Thyroid hormone metabo- （收稿日期：2021-07-19 修回日期：2021-12-15）
lite 3-iodothyronamine（T1AM）alleviates hypoxia/reoxy- （编辑：邹丽娟）

·250 · China Pharmacy 2022 Vol. 33 No. 2 中国药房 2022年第33卷第2期